ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2026
A Randomized Controlled Trial Comparing Low-FODMAP and Gluten-Free Diets on Gastrointestinal Symptoms, Nutritional Status, and Quality of Life in Irritable Bowel Syndrome.
Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aims: Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that requires a symptom-based treatment approach, in which dietary and lifestyle modifications play a central role in reducing symptoms and improving quality of life. Therefore, dietary strategies should be individualized. This study compared the short term effects of low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) and gluten-free diets on symptom severity, health-related quality of life, dietary intake, and anthropometric measurements in individuals with IBS. Materials and Methods: In this 3-arm, parallel-group randomized controlled trial, 63 adults diagnosed with IBS according to the Rome IV criteria were enrolled. Participants were randomly assigned to a low-FODMAP diet (n = 21), a gluten-free diet (n = 21), or a control group (n = 21). The intervention period lasted 4 weeks. Assessments were conducted at baseline and after the intervention using the IBS Symptom Severity Score (IBS-SSS), IBS Quality of Life questionnaire (IBS-QOL), IBS Visual Analog Scale, 3-day dietary intake records, and anthropometric measurements. Results: Both intervention groups demonstrated reductions in IBS-SSS scores and improvements in IBS-QOL scores (P < .001). After adjustment for baseline values, a significant between-group difference was observed in quality of life (P < .001), whereas no significant difference was found in symptom severity (P > .05). Significant between-group differences were also observed in body weight, body mass index, waist circumference, waist-to-hip ratio, and carbohydrate intake. Conclusion: Low-FODMAP and gluten-free diets may improve quality of life in individuals with IBS in the short term. After adjustment for baseline values, a between-group difference was observed only in quality of life, whereas no difference was found in symptom severity. These findings suggest that both dietary interventions may represent effective nutritional strategies for the management of IBS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.